Literature DB >> 18621790

Detection of visual-field deterioration by Glaucoma Progression Analysis and Threshold Noiseless Trend programs.

V T Diaz-Aleman1, A Anton, M Gonzalez de la Rosa, Z K Johnson, S McLeod, A Azuara-Blanco.   

Abstract

BACKGROUND: To compare the ability of Glaucoma Progression Analysis (GPA) and Threshold Noiseless Trend (TNT) programs to detect visual-field deterioration.
METHODS: Patients with open-angle glaucoma followed for a minimum of 2 years and a minimum of seven reliable visual fields were included. Progression was assessed subjectively by four masked glaucoma experts, and compared with GPA and TNT results. Each case was judged to be stable, deteriorated or suspicious of deterioration
RESULTS: A total of 56 eyes of 42 patients were followed with a mean of 7.8 (SD 1.0) tests over an average of 5.5 (1.04) years. Interobserver agreement to detect progression was good (mean kappa = 0.57). Progression was detected in 10-19 eyes by the experts, in six by GPA and in 24 by TNT. Using the consensus expert opinion as the gold standard (four clinicians detected progression), the GPA sensitivity and specificity were 75% and 83%, respectively, while the TNT sensitivity and specificity was 100% and 77%, respectively.
CONCLUSION: TNT showed greater concordance with the experts than GPA in the detection of visual-field deterioration. GPA showed a high specificity but lower sensitivity, mainly detecting cases of high focality and pronounced mean defect slopes.

Entities:  

Mesh:

Year:  2008        PMID: 18621790     DOI: 10.1136/bjo.2007.136739

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  9 in total

Review 1.  Detection of visual field progression in glaucoma with standard achromatic perimetry: a review and practical implications.

Authors:  Kouros Nouri-Mahdavi; Nariman Nassiri; Annette Giangiacomo; Joseph Caprioli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-26       Impact factor: 3.117

Review 2.  [Pulsar perimetry. A review and new results].

Authors:  M Gonzalez de la Rosa; M Gonzalez-Hernandez
Journal:  Ophthalmologe       Date:  2013-02       Impact factor: 1.059

3.  Perimetric progression using the Visual Field Index and the Advanced Glaucoma Intervention Study score and its clinical correlations.

Authors:  Juan Gros-Otero; Miguel Castejón; Javier Paz-Moreno; Dimitrios Mikropoulos; Miguel Teus
Journal:  J Optom       Date:  2014-09-01

4.  Glaucoma Progression Analysis software compared with expert consensus opinion in the detection of visual field progression in glaucoma.

Authors:  Angelo P Tanna; Donald L Budenz; Jagadeesh Bandi; William J Feuer; Robert M Feldman; Leon W Herndon; Douglas J Rhee; Julia Whiteside-de Vos; Joyce Huang; Douglas R Anderson
Journal:  Ophthalmology       Date:  2011-12-02       Impact factor: 12.079

5.  The 24-2 Visual Field Guided Progression Analysis Can Miss the Progression of Glaucomatous Damage of the Macula Seen Using OCT.

Authors:  Donald C Hood; Sol La Bruna; Emmanouil Tsamis; Ari Leshno; Bruna Melchior; Jennifer Grossman; Jeffrey M Liebmann; Carlos Gustavo De Moraes
Journal:  Ophthalmol Glaucoma       Date:  2022-03-28

6.  Point-wise variability of threshold sensitivity of 24-2 and 10-2 visual fields.

Authors:  Aparna Rao; Harsha L Rao; Debananda Padhy
Journal:  Taiwan J Ophthalmol       Date:  2022-05-26

7.  Agreement between event-based and trend-based glaucoma progression analyses.

Authors:  H L Rao; T Kumbar; A U Kumar; J G Babu; S Senthil; C S Garudadri
Journal:  Eye (Lond)       Date:  2013-04-19       Impact factor: 3.775

8.  Filtering data from the collaborative initial glaucoma treatment study for improved identification of glaucoma progression.

Authors:  Greggory J Schell; Mariel S Lavieri; Joshua D Stein; David C Musch
Journal:  BMC Med Inform Decis Mak       Date:  2013-12-21       Impact factor: 2.796

9.  A New Graphical Tool for Assessing Visual Field Progression in Clinical Populations.

Authors:  Susan R Bryan; David P Crabb
Journal:  Transl Vis Sci Technol       Date:  2018-02-28       Impact factor: 3.283

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.